|[October 15, 2013]
Caldera Medical to Introduce Three New Products at the American Urogynecologic Society 34th Annual Scientific Meeting in Las Vegas
AGOURA HILLS, Calif. --(Business Wire)--
Caldera Medical, a leader in the development of implants for the
treatment of female Stress Urinary Incontinence, has announced it will
introduce three of its newest FDA cleared solutions for SUI, Desara®
Mini, Desara® SL, and Desara® Blue, at the
American Urogynecologic Society (AUGS) 34th Annual Scientific
Meeting running from October 16th through October 19th
in Las Vegas, NV.
Desara® Blue is a blue version of Caldera Medical's Desara®
universal sling system and provides surgeons with their choice
of multiple surgical approaches by utilizing reusable instrumentation.
The blue color provides exceptional visibility both during and after
Desara® SL utilizes the same proven Desara® mesh
in a shorter 12 cm length to minimize the amount of mesh implanted. A
shorter 12 cm sling length has been shown to significantly reduce
post-operative groin pain, making patients more comfortable while
delivering equivalent safety and efficacy as traditional slings.
Desara® Mini is a mini sling which combines the proven
Desara mesh with a secure fixation system that allows for ling
placement in a less invasive, single incision procedure.
"We enjoy coming to AUGS as it is an opportunity for us to highlight our
broad portfolio of innovative solutions for the treatment of SUI, one of
the primary conditions treated by urogynecologists. Since our inception
we have focused on providing surgeons with a breadth of choices to meet
their needs," commented Bryon L. Merade, Chairman and CEO, adding "The
addition of three new products for the treatment of SUI in 2013, Desara®
Mini, Desara® SL, and Desara® Blue, demonstrates
our continued commitment to providing our physician customers with the
most comprehensive line of solutions for the treatment of Stress Urinary
Caldera Medical's other product lines include the Desara®
Sling System for treatment of Stress Urinary Incontinence and Vertessa™
Lite, a supple, lightweight yet strong polypropylene mesh for use
in abdominal sacrocolpopexy procedures for the treatment of Pelvic Organ
Prolapse (POP). Stress Urinary Incontinence, the most prevalent form of
incontinence among women, affects an estimated 15 million adult women in
the U.S. and incontinence is the second leading cause of
institutionalization in older women. Pelvic Organ Prolapse (POP) is one
of the most common quality of life conditions facing women with nearly
50% of all women who give birth vaginally developing POP. A woman's
lifetime probability for undergoing a surgical treatment to correct POP
is approximately 11%. Abdominal sacrocolpopexy procedures are expected
to grow approximately 15% in 2013 due to a shift from transvaginal
prolapse repair procedures.
About Caldera Medical
Caldera Medical is dedicated to improving quality of life for women.
Caldera Medical develops and markets differentiated surgical implants
specifically for the treatment of Stress Urinary Incontinence and Pelvic
Organ Prolapse across the gynecology, urology and urogynecology
Caldera Medical is a privately held company located in Agoura Hills,
California. For more information, visit Caldera Medical's Web site at www.calderamedical.com.
[ Back To Technology News's Homepage ]